Real World Experience of Vedolizumab in Pediatric Inflammatory Bowel Disease

被引：0
|
作者：
Whitney, Annette [1 ]
Sarles, Harry E., Jr. [2 ]
Claudia, Schroeder P. [3 ]
Okoro, Tracy C. [3 ]
Van Anglen, Lucinda J. [3 ]
机构：
[1] Digest Hlth Associates Texas, Dallas, TX USA
[2] DHAT Res Inst, Richardson, TX USA
[3] Healix Infus Therapy, Sugar Land, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
703
引用
收藏
页码：S396 / S396
页数：1
相关论文
共 50 条
  • [31] Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting
    Kolehmainen, Sara
    Ylisaukko-Oja, Tero
    Jokelainen, Jari
    Koivusalo, Mirkka
    Jokiranta, T. Sakari
    Sipponen, Taina
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (08) : 906 - 913
  • [32] RISK OF INFECTIOUS COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH VEDOLIZUMAB: A REAL LIFE EXPERIENCE
    Apolito, P.
    Innocenti, T.
    Roselli, J.
    Parisio, L.
    Macri, G.
    Bagnoli, S.
    Rogai, F.
    Galli, A.
    Milla, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2020, 52 : S123 - S123
  • [33] CLINICAL EXPERIENCE WITH VEDOLIZUMAB TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE
    Al-Bawardy, Badr
    Ramos, Guilherme Piovezani
    Willrich, Maria Alice V.
    Park, Sang Hyoung
    Aniwan, Satimai
    Raffals, Laura H.
    Tremaine, William J.
    Loftus, Edward V.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S821 - S822
  • [34] Real World Effectiveness, Safety and Pharmacokinetics of Switching Intravenous Vedolizumab Maintenance treatment to Subcutaneous Vedolizumab Therapy for Inflammatory Bowel Disease
    Volkers, A.
    Straatmijer, T.
    Duijvestein, M.
    Sales, A.
    Levran, A.
    van Schaik, F.
    Jeroen, M.
    Gecse, K.
    Ponsioen, C.
    Grootjans, J.
    Hanzel, J.
    Tack, G.
    Jansen, J.
    Hoentjen, F.
    de Boer, N.
    van der Marel, S.
    Dijkstra, G.
    Oldenburg, B.
    Lowenberg, M.
    van der Meulen, A.
    D'Haens, G.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I108 - I109
  • [35] Long-Term Efficacy of Vedolizumab in Pediatric Inflammatory Bowel Disease
    Sarles, Harry E., Jr.
    Whitney, Annette E.
    Kuten, Samantha A.
    Van Anglen, Lucinda J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S643 - S644
  • [36] VEDOLIZUMAB AND METHOTREXATE COMBINATION FOR MODERATE TO SEVERE PEDIATRIC INFLAMMATORY BOWEL DISEASE
    Rountree, Carl B.
    Williams, Ted
    Hayes, Chris
    Wester, Jessica
    Anderson, Melissa
    Maddox, Megan
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S754 - S754
  • [37] Postoperative complications of pediatric patients with inflammatory bowel disease treated with vedolizumab
    Zimmerman, Lori A.
    Zalieckas, Jill M.
    Shamberger, Robert C.
    Bousvaros, Athos
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2018, 53 (07) : 1330 - 1333
  • [38] REAL WORLD EFFECTIVENESS OF VEDOLIZUMAB OVER ONE YEAR IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Khalid, Javaria M.
    Loftus, Edward V.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S338 - S338
  • [39] Real World Treatment Persistence With Vedolizumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Demuth, Dirk
    Patel, Haridarshan
    Adsul, Shashi
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S369 - S370
  • [40] Real-World Effectiveness of Vedolizumab as Induction Therapy in Inflammatory Bowel Disease: A Meta-Analysis
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Khalid, Javaria
    Loftus, Edward, Jr.
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S24 - S24
12345